Table 2.
Insulin target | Phenotype of (liver-specific) KO mice | Potential mechanism of action | Reference |
---|---|---|---|
| |||
IRS1, IRS2 | Hyperglycemia, hyperinsulinemia | Induction of gluconeogenic genes | 29–31 |
PI3K (p110-α and p110-β subunits) | Diet-induced liver steatosis ↓ Glucose intolerance (p110-α) ↑ |
Insulin-induced Akt phosphorylation at Ser473 ↓ | 135 |
PDK1 | Glucose tolerance ↓ Pyruvate tolerance ↓ Insulin sensitivity ↑ |
Disruption of acute AKT-dependent insulin signaling | 34 |
Akt2 | Insulin resistance ↑ Hepatic glucose production ↑ |
Increased expression of FOXO1 target genes | 20, 38, 39 |
p38 MAPK | Glycemia ↓ Gluconeogenesis ↓ |
Decreased transcription of Pparg, Ppargc1a | 46 |
FoxO1 | Fasting glucose ↓ Gluconeogenic gene expression ↓ |
Direct regulation of G6pc and Pck1 transcription | 67–70 |
PGC-1α | Gluconeogenic gene expression ↑ Loss of feeding-induced regulation |
Regulation of G6pc and Pck1 transcription | 96 |